Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in Foreign Trade Bank
BlackRock, Inc. has reported a 5.6% beneficial ownership stake in FOREIGN TRADE BANK OF LATIN AMERICA INC as of December 31, 2025, held for passive investment purposes.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in ORIC Pharmaceuticals
BlackRock, Inc. has reported a 5.6% passive ownership stake in ORIC Pharmaceuticals Inc., holding 5,473,145 shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Reports 6.7% Stake in Quantum Computing Inc.
BlackRock, Inc. has disclosed a 6.7% beneficial ownership stake in Quantum Computing Inc., holding over 15 million common shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 4.9% Stake in FIGS, Inc. Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership in FIGS, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Ellington Financial to 15.3%
BlackRock, Inc. has reported an increased beneficial ownership of 15.3% in Ellington Financial Inc.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Customers Bancorp Stake to 13.6%
BlackRock, Inc. has increased its beneficial ownership in Customers Bancorp Inc. to 13.6% of common stock, holding 4,634,097 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Oklo Inc. Class A to 9.2%
BlackRock, Inc. has reported an increased beneficial ownership of 9.2% in Oklo Inc. Class A shares, holding 14,419,350 shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in Charter Communications
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.1% of Charter Communications, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Boosts Stake in BrightSpring Health to 9.9%
BlackRock, Inc. has disclosed a 9.9% beneficial ownership stake in BrightSpring Health Services Inc., holding over 18 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Amends Anteris Technologies Stake to 4.9%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% beneficial ownership in Anteris Technologies Global Corp's common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 8.1% Stake in Archer Aviation
BlackRock, Inc. has disclosed an 8.1% beneficial ownership stake in Archer Aviation Inc.'s Class A Stock, holding 52,989,964 shares.
NYSE
SCHEDULE 13G/A: BlackRock Amends Axon Enterprise Stake to 9.5%
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 9.5% beneficial ownership stake in Axon Enterprise Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in BRC Inc.
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in BRC Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts BlueLinx Holdings Stake to 11.8%
BlackRock, Inc. has disclosed an 11.8% beneficial ownership stake in BlueLinx Holdings Inc., holding 926,837 shares of common stock.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in First United Corp
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in First United Corp's common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Annexon Stake to 6.1%
BlackRock, Inc. has reported an increased beneficial ownership of 6.1% in Annexon Inc.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.9% Stake in Intuitive Machines
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.9% beneficial ownership stake in Intuitive Machines, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 6.8% Stake in American Battery Tech
BlackRock, Inc. has reported a 6.8% passive ownership stake in American Battery Technology Co, holding over 8.8 million shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.1% Stake in Amylyx Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% beneficial ownership stake in Amylyx Pharmaceuticals, Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in Inseego Corp
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in Inseego Corp. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Insperity to 13.7%
BlackRock, Inc. has reported a significant beneficial ownership stake of 13.7% in Insperity Inc., holding over 5.1 million shares.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.3% Stake in INHIBRX BIOSCIENCES
BlackRock, Inc. has filed a Schedule 13G, reporting a 5.3% beneficial ownership stake in INHIBRX BIOSCIENCES, INC. as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Hewlett Packard Enterprise Stake to 8.9%
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 8.9% in Hewlett Packard Enterprise Co.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.9% Stake in Forge Global Holdings
BlackRock, Inc. has reported a 5.9% beneficial ownership stake in Forge Global Holdings, Inc., holding 813,292 shares of common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts BioMarin Stake to 9.1%
BlackRock, Inc. has reported a 9.1% beneficial ownership stake in BioMarin Pharmaceutical Inc., holding 17,560,751 common shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Stake in ACRES Realty
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.4% beneficial ownership stake in ACRES Commercial Realty Corp common stock.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in Cimpress PLC
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in Cimpress PLC, holding 1,261,757 common shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in CB Financial Services
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in CB Financial Services Inc., holding 254,204 shares of common stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in NioCorp Developments
BlackRock, Inc. has reported a 5.2% beneficial ownership stake in NioCorp Developments Ltd., holding over 6.18 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in Cass Information Systems
BlackRock, Inc. has reported an increased beneficial ownership of 6.8% in Cass Information Systems Inc., holding 895,886 shares of common stock.